Elena Stroppiana

540 total citations
19 papers, 230 citations indexed

About

Elena Stroppiana is a scholar working on Dermatology, Immunology and Physiology. According to data from OpenAlex, Elena Stroppiana has authored 19 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Dermatology, 13 papers in Immunology and 10 papers in Physiology. Recurrent topics in Elena Stroppiana's work include Psoriasis: Treatment and Pathogenesis (13 papers), Dermatology and Skin Diseases (11 papers) and Asthma and respiratory diseases (9 papers). Elena Stroppiana is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (13 papers), Dermatology and Skin Diseases (11 papers) and Asthma and respiratory diseases (9 papers). Elena Stroppiana collaborates with scholars based in Italy, Belarus and United States. Elena Stroppiana's co-authors include Anna Verrone, Pietro Quaglino, Paolo Dapavo, Luca Mastorino, Simone Ribero, Michela Ortoncelli, Caterina Cariti, Niccolò Siliquini, Simona Osella‐Abate and Paola Savoia and has published in prestigious journals such as PLoS ONE, British Journal of Dermatology and Journal of Clinical Medicine.

In The Last Decade

Elena Stroppiana

18 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elena Stroppiana Italy	10	117	107	58	49	47	19	230
E. del Alcázar Spain	9	189 1.6×	173 1.6×	22 0.4×	52 1.1×	41 0.9×	17	269
Luigi Gargiulo Italy	13	237 2.0×	240 2.2×	62 1.1×	78 1.6×	54 1.1×	48	381
C. Belajouza Tunisia	9	28 0.2×	74 0.7×	37 0.6×	26 0.5×	45 1.0×	52	242
Cristina Mugheddu Italy	9	116 1.0×	84 0.8×	10 0.2×	22 0.4×	46 1.0×	22	200
Chrysovalantis Korfitis Greece	10	114 1.0×	189 1.8×	42 0.7×	7 0.1×	29 0.6×	19	273
C. Bodemer France	7	45 0.4×	78 0.7×	17 0.3×	36 0.7×	15 0.3×	31	311
H. Vázquez‐Veiga Spain	7	112 1.0×	102 1.0×	16 0.3×	12 0.2×	39 0.8×	27	204
César Daniel Villarreal‐Villarreal Mexico	7	28 0.2×	47 0.4×	25 0.4×	11 0.2×	20 0.4×	17	233
Cynthia Marie Carver DeKlotz United States	8	45 0.4×	97 0.9×	42 0.7×	49 1.0×	34 0.7×	34	271
Riccardo Pellicano Italy	10	58 0.5×	104 1.0×	31 0.5×	30 0.6×	84 1.8×	15	293

Countries citing papers authored by Elena Stroppiana

Since Specialization

Citations

This map shows the geographic impact of Elena Stroppiana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Stroppiana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Stroppiana more than expected).

Fields of papers citing papers by Elena Stroppiana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Stroppiana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Stroppiana. The network helps show where Elena Stroppiana may publish in the future.

Co-authorship network of co-authors of Elena Stroppiana

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Stroppiana. A scholar is included among the top collaborators of Elena Stroppiana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Stroppiana. Elena Stroppiana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2025). Drug survival, effectiveness and safety of risankizumab for moderate-to-severe psoriasis for up to 4 years. Clinical and Experimental Dermatology. 51(1). 35–41.

Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2025). Drug survival, effectiveness and safety of guselkumab for moderate-to-severe psoriasis for up to 4 years. Clinical and Experimental Dermatology. 50(8). 1590–1597. 1 indexed citations

Mastorino, Luca, Paolo Dapavo, Michela Ortoncelli, et al.. (2024). Clinical characteristics and response to biological therapies for inverse psoriasis: a real‐life comparison between the therapeutic effects of anti‐IL ‐23 and anti‐IL ‐17 agents. International Journal of Dermatology. 63(12). 1735–1739. 3 indexed citations

Mastorino, Luca, Michela Ortoncelli, Chiara Astrua, et al.. (2024). Drug Survival and Clinical Course of Patients with Cancer Treated with Biologic Therapy for Psoriasis. Journal of Clinical Medicine. 13(21). 6546–6546. 4 indexed citations

Mastorino, Luca, Paolo Dapavo, Caterina Cariti, et al.. (2024). Drug Survival, Safety, and Effectiveness of Secukinumab for up to 5 Years in Patients with Psoriasis and Psoriatic Arthritis: A Long-Term Real-Life Experience. Journal of Personalized Medicine. 14(7). 718–718. 1 indexed citations

Mastorino, Luca, Paolo Dapavo, Francesco Leo, et al.. (2024). Drug survival, effectiveness, and safety of brodalumab for moderate‐to‐severe psoriasis up to 3 years. International Journal of Dermatology. 63(7). 922–928. 2 indexed citations

Mastorino, Luca, Caterina Cariti, Niccolò Siliquini, et al.. (2023). Effectiveness of Brodalumab on Scalp, Palmoplantar, and Genital Psoriasis: A Descriptive Pilot Study. Dermatologic Therapy. 2023(1). 2 indexed citations

Mastorino, Luca, Paolo Dapavo, Francesco Leo, et al.. (2023). Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years. Journal of the European Academy of Dermatology and Venereology. 38(3). 568–575. 11 indexed citations

Mastorino, Luca, Paolo Frigatti, Gabriele Roccuzzo, et al.. (2023). Clinical effectiveness of IL-17 and IL-23 inhibitors on difficult-to-treat psoriasis areas (scalp, genital, and palmoplantar sites): a retrospective, observational, single-center, real-life study. Expert Opinion on Biological Therapy. 23(9). 929–936. 10 indexed citations

10.

Giordano, Silvia, Paolo Dapavo, Michela Ortoncelli, et al.. (2023). Interclass Switch between IL17 and IL23 Inhibitors in Psoriasis: A Real-Life, Long-Term, Single-Center Experience. Journal of Clinical Medicine. 12(24). 7503–7503. 7 indexed citations

11.

Mastorino, Luca, Paolo Dapavo, Caterina Cariti, et al.. (2023). Drug survival and clinical effectiveness of secukinumab, ixekizumab, brodalumab, guselkumab, risankizumab, tildrakizumab for psoriasis treatment. JDDG Journal der Deutschen Dermatologischen Gesellschaft. 22(1). 34–42. 24 indexed citations

12.

Mastorino, Luca, Caterina Cariti, Anna Verrone, et al.. (2023). Efficacy of anti‐IL‐23 and anti‐IL‐17 after adalimumab failure in psoriatic patients. Journal of the European Academy of Dermatology and Venereology. 37(9). 1848–1853. 14 indexed citations

13.

Dapavo, Paolo, Niccolò Siliquini, Luca Mastorino, et al.. (2021). Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study. Journal of Dermatological Treatment. 33(4). 2352–2357. 32 indexed citations

14.

Sidoti, Francesca, Simone Ribero, Ivano Dal Conte, et al.. (2019). Recurrent herpes labialis and Herpes simplex virus-1 genitalis: what is the link?. Giornale Italiano di Dermatologia e Venereologia. 154(5). 529–532. 4 indexed citations

15.

Stefanelli, Paola, Maria Fenicia Vescio, Maria Paola Landini, et al.. (2017). Time trend analysis (2009-2016) of antimicrobial susceptibility in Neisseria gonorrhoeae isolated in Italy following the introduction of the combined antimicrobial therapy. PLoS ONE. 12(12). e0189484–e0189484. 14 indexed citations

16.

Virgili, Annarosa, Alessandro Borghi, Simone Cazzaniga, et al.. (2016). New insights into potential risk factors and associations in genital lichen sclerosus: Data from a multicentre Italian study on 729 consecutive cases. Journal of the European Academy of Dermatology and Venereology. 31(4). 699–704. 38 indexed citations

17.

Savoia, Paola, Simona Osella‐Abate, Federica Marenco, et al.. (2011). Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34‐year single‐institution study. Journal of the European Academy of Dermatology and Venereology. 26(7). 882–888. 28 indexed citations

18.

Savoia, Paola, Elena Stroppiana, Giovanni Cavaliere, et al.. (2011). Skin cancers and other cutaneous diseases in renal transplant recipients: a single Italian center observational study. European Journal of Dermatology. 21(2). 242–247. 17 indexed citations

19.

Ponti, Renata, Massimiliano Bergallo, Cristina Costa, et al.. (2008). Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role. British Journal of Dermatology. 159(5). 1131–7. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact